22 results
8-K
EX-10.1
DYAI
Dyadic International Inc., DE
12 Apr 23
Dyadic Announces Expanded Licensing Agreement to Develop and Commercialize Vaccines and Biologics for African Continent
8:30am
” [***]:
(a) trade, cash and quantity discounts;
(b) charge-back payments and rebates granted to Third Parties, including managed health care organizations
8-K
EX-10.1
DYAI
Dyadic International Inc., DE
17 Dec 21
Dyadic Announces Research, License and Collaboration Agreement with Janssen
7:10am
in federal health care programs such as Medicare or Medicaid by the Office of the Inspector General (OIG/HHS) of the U.S. Department of Health and Human
10-K
igx9zk i9eadygocm
27 Mar 19
Annual report
4:30pm
10-12G/A
f1cqjwpo3rq65hawn8pz
8 Feb 19
Registration of securities (amended)
5:26pm
10-12G
qp1iewe0z 38uxd5
14 Jan 19
Registration of securities
5:23pm
10-12G
EX-10.16
d200jd2yq19u0 gz
14 Jan 19
Registration of securities
5:23pm
10-12G/A
k30y9t
18 Dec 18
Registration of securities (amended)
4:04pm
10-12G
ffqkdpx 1ms2
5 Nov 18
Registration of securities
7:32am
10-12G
EX-10.16
aj67o
5 Nov 18
Registration of securities
7:32am
424B3
vmej o7rci
22 Jan 07
Prospectus supplement
12:00am
S-3
bekcbz2 rlb0yt4xmm
21 Dec 06
Shelf registration
12:00am
424B3
482 va20y7mfi4sxxb
12 Aug 05
Prospectus supplement
12:00am
POS AM
2kp029r1l
22 Jul 05
Prospectus update (post-effective amendment)
12:00am
424B3
8r4kja3 cob3un
1 Feb 05
Prospectus supplement
12:00am